Portal de investigação
Systemic Transthyretin Amyloidosis: Carpal Tunnel Syndrome in a Portuguese Population (CarPoS) - NCT05409833
Dados básicos
- Código:
- Estudo Observacional Académico (CarPoS)
- Protocolo:
- Estudo Observacional Académico (CarPoS)
- EUDRACT:
- NCT:
- NCT05409833
- Centro:
- Dotação:
- Ano de início:
- 2020
- Ano de conclusão:
Objectivos do projeto
Tipo de Estudo: Estudo Observacional – Iniciativa do Investigador; Subtipo: Estudo de controlo; Fase: Cross-sectional; Natureza do Promotor: Academia – Tipo não comercial; Tipo de Centro: Unicêntrico – Cuidados Secundários – Centro de Ensaio: CHUSJ – Doença investigada: Amiloidose – Participantes recrutados: 30;
Documentos
- Não há documentos
Participantes
Unidades de investigação
Stakeholders - Promotores
Outputs do ensaio clínico
ADALIMUMAB AND NUMBER OF PREVIOUS BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS AS PREDICTIVE FACTORS FOR THE DEVELOPMENT OF IMMUNE-MEDIATED SKIN LESIONS
Martins, A; (...); Costa, L
Meeting Abstract. 10.1136/annrheumdis-2023-eular.2061. 2023
CAN WE PREDICT THE RISK FACTORS FOR SWITCHING IN THE FIRST YEAR OF THERAPY WITH BDMARD IN PATIENTS WITH RHEUMATOID ARTHRITIS?
Martins, A; (...); Costa, L
Meeting Abstract. 10.1136/annrheumdis-2023-eular.4764. 2023
Cardiovascular magnetic resonance in muscular dystrophies: looking ahead
Article. 10.4081/monaldi.2024.2851. 2024
Cardiovascular Magnetic Resonance Versus Histopathologic Study for Diagnosis of Benign and Malignant Cardiac Tumours: A Systematic Review and Meta-Analysis
N?brega, S; (...); Martins, E.
Article. 10.4250/jcvi.2023.0028. 2023
cTnI, BNP and CRP profiling after seizures in patients with drug-resistant epilepsy
Faria, MT; (...); Martins, E.
Article. 10.1016/j.seizure.2020.06.003. 2020
Does the type of seizure influence heart rate variability changes?
Faria, MT; (...); Martins, E.
Article. 10.1016/j.yebeh.2021.108453. 2022
DRUG-INDUCED LUPUS ERYTHEMATOSUS SECONDARY TO ANTI-TNF-A AGENTS IN PATIENTS WITH SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS
Martins, A; (...); Costa, L
Meeting Abstract. 10.1136/annrheumdis-2021-eular.2953. 2021
Heart rate variability in patients with refractory epilepsy: The influence of generalized convulsive seizures
Faria, MT; (...); Martins, E.
Article. 10.1016/j.eplepsyres.2021.106796. 2021
Heart rate variability in patients with refractory epilepsy: The influence of generalized convulsive seizures.
Article. 2021
IMMUNE-MEDIATED SKIN LESIONS RELATED TO BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: A 22-YEAR EXPERIENCE OF A TERTIARY CENTER
Martins, A; (...); Costa, L
Meeting Abstract. 10.1136/annrheumdis-2023-eular.2044. 2023
IN PREVIOUSLY BIOLOGIC-NAIVE RHEUMATIC PATIENTS WITH DRUG INDUCED LUPUS SECONDARY TO A FIRST ANTI-TNF THERAPY, IS IT SAFE TO SWITCH TO A SECOND ANTI-TNF-a AGENT?
Martins, A; (...); Costa, L
Meeting Abstract. 10.1136/annrheumdis-2021-eular.2992. 2021
IS MINOR SALIVARY GLAND HISTOLOGY A GOOD BIOMARKER SCORE TO PREDICT THE EXTRAGLANDULAR INVOLVEMENT IN PATIENTS WITH PRIMARY SJOGREN'S SYNDROME?
Martins, A; (...); Costa, L
Meeting Abstract. 10.1136/annrheumdis-2021-eular.3220. 2021
IS THERE AN ASSOCIATION BETWEEN AUTOANTIBODIES INDUCTION AND LOSS OF THERAPEUTIC EFFICACY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS TREATED WITH ANTI-TNF-a AGENTS?
Martins, A; (...); Costa, L
Meeting Abstract. 10.1136/annrheumdis-2021-eular.1287. 2021
Mavacamten, a novel revolutionizing therapy in hypertrophic obstructive cardiomyopathy: A literature review
Aguiar, T, Martins, E.
Review. 10.1016/j.repc.2021.09.013. 2022
Mavacamten, a novel revolutionizing therapy in hypertrophic obstructive cardiomyopathy: A literature review.
Review. 2022
PSORIATIC ARTHRITIS RELATED FATIGUE: WHAT IS THE MAGNITUDE OF THIS PROBLEM AND WHAT ARE THE CORRELATED FACTORS? A CROSS-SECTIONAL STUDY.
Martins, A; (...); Costa, L
Meeting Abstract. 10.1136/annrheumdis-2022-eular.2974. 2022
Recommendations for the Management of Cardiomyopathy Mutation Carriers: Evidence, Doubts, and Intentions
Couto, JF, Martins, E.
Review. 10.3390/jcm12144706. 2023
Recommendations for the Management of Cardiomyopathy Mutation Carriers: Evidence, Doubts, and Intentions.
Review. 2023
Severe and life-threatening onset of systemic lupus erythematosus
Martins, A; (...); Costa, L
Article. 10.1016/j.reuma.2022.09.006. 2023
Takotsubo Syndrome in a Rheumatoid Arthritis Patient Under Tofacitinib: A Case Report
Garcia, S; (...); Bernardes, MAB -
Article. 10.1016/j.reuma.2021.06.003. 2021
Takotsubo Syndrome in a Rheumatoid Arthritis Patient Under Tofacitinib: A Case Report.
Article. 2022
Temporal trends of lipid control in very high cardiovascular risk patients
Ara?jo, PM; (...); Maciel, MJAB -
Article. 10.1016/j.repce.2020.10.021. 2021
The association between pre-existing heart failure and cancer incidence: A systematic review and meta-analysis
Article. 10.1016/j.repc.2023.10.015. 2024
The association between pre-existing heart failure and cancer incidence: A systematic review and meta-analysis.
Review. 2024
WHAT IS THE REAL IMPACT OF DEPRESSION ON CLINICAL RESPONSE TO THERAPY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS?
Martins, A; (...); Costa, L
Meeting Abstract. 10.1136/annrheumdis-2023-eular.1101. 2023
